NCT06498011 COgnitive-somatoSensory-MOtor Training to Improve Arm and Hand Function After Stroke (iCOSMO)
| NCT ID | NCT06498011 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Health Network, Toronto |
| Condition | Stroke |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2024-08-01 |
| Primary Completion | 2027-07-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2024-08-01 with a primary completion date of 2027-07-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The iCOSMO study investigates the feasibility and beneficial effects of an intervention combining sensation, motor and cognition to improve arm and hand function after chronic stroke.
Eligibility Criteria
Inclusion Criteria: * Clinical diagnosis of stroke * Must be more than 6 months post-stroke * Must be above 18 years old * Must have some motor and/or somatosensory deficits in the upper limbs Exclusion Criteria: * A prior history of central nervous system dysfunction other than stroke * Upper limb deficits resulting from non-stroke pathology * Inability to cooperate, follow instructions or provide consent
Contact & Investigator
Mark Bayley, MD
PRINCIPAL INVESTIGATOR
Toronto Rehabilitation Institute
Frequently Asked Questions
Who can join the NCT06498011 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06498011 currently recruiting?
Yes, NCT06498011 is actively recruiting participants. Contact the research team at urvashy.gopaul@uhn.ca for enrollment information.
Where is the NCT06498011 trial being conducted?
This trial is being conducted at Toronto, Canada.
Who is sponsoring the NCT06498011 clinical trial?
NCT06498011 is sponsored by University Health Network, Toronto. The principal investigator is Mark Bayley, MD at Toronto Rehabilitation Institute. The trial plans to enroll 40 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.